Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease — Stella

Home/Neuropathology/Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease

View on ClinicalTrials.gov

Recruiting

Back to Neuropathology trials

Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

CHU de Montpellier, Montpellier, Hérault

Key details

Sponsor

University Hospital, Montpellier

Collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment target

~50 participants

Started

February 2025

Primary completion

August 2027

Age range

50 Years – 85 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.